|
Volumn 28, Issue 7, 2010, Pages 636-
|
Merck ditches biogeneric.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL PRODUCT;
GENERIC DRUG;
HEMOPOIETIC GROWTH FACTOR;
DRUG INDUSTRY;
HUMAN;
NOTE;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
BIOLOGICAL PRODUCTS;
DECISION MAKING, ORGANIZATIONAL;
DRUG INDUSTRY;
DRUGS, GENERIC;
HEMATOPOIETIC CELL GROWTH FACTORS;
HUMANS;
|
EID: 78049505322
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0710-636a Document Type: Note |
Times cited : (3)
|
References (0)
|